368 related articles for article (PubMed ID: 23594883)
1. Three are better than one: plasminogen receptors as cancer theranostic targets.
Ceruti P; Principe M; Capello M; Cappello P; Novelli F
Exp Hematol Oncol; 2013 Apr; 2(1):12. PubMed ID: 23594883
[TBL] [Abstract][Full Text] [Related]
2. New Insight on the Role of Plasminogen Receptor in Cancer Progression.
Kumari S; Malla R
Cancer Growth Metastasis; 2015; 8():35-42. PubMed ID: 26279629
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen Receptors in Human Malignancies: Effects on Prognosis and Feasibility as Targets for Drug Development.
Gonias SL; Zampieri C
Curr Drug Targets; 2020; 21(7):647-656. PubMed ID: 31755385
[TBL] [Abstract][Full Text] [Related]
4. α-Enolase: a promising therapeutic and diagnostic tumor target.
Capello M; Ferri-Borgogno S; Cappello P; Novelli F
FEBS J; 2011 Apr; 278(7):1064-74. PubMed ID: 21261815
[TBL] [Abstract][Full Text] [Related]
5. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
Sharma MC; Sharma M
Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
[TBL] [Abstract][Full Text] [Related]
6. Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target.
Hsiao KC; Shih NY; Fang HL; Huang TS; Kuo CC; Chu PY; Hung YM; Chou SW; Yang YY; Chang GC; Liu KJ
PLoS One; 2013; 8(7):e69354. PubMed ID: 23894455
[TBL] [Abstract][Full Text] [Related]
7. [The clinical prospects for the study of the plasminogen activation system in breast cancer].
Gershteĭn ES; Kushlinskiĭ NE
Vestn Ross Akad Med Nauk; 1999; (8):58-61. PubMed ID: 10487126
[TBL] [Abstract][Full Text] [Related]
8. Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy.
Bharadwaj AG; Holloway RW; Miller VA; Waisman DM
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921488
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness.
Obermajer N; Doljak B; Kos J
Mol Cancer; 2009 Oct; 8():88. PubMed ID: 19845941
[TBL] [Abstract][Full Text] [Related]
10. [The urokinase-type plasminogen activator system and its role in tumor progression].
Kugaevskaya EV; Gureeva TA; Timoshenko OS; Solovyeva NI
Biomed Khim; 2018 Nov; 64(6):472-486. PubMed ID: 30632975
[TBL] [Abstract][Full Text] [Related]
11. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
[TBL] [Abstract][Full Text] [Related]
12. Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers.
Sharma MC
Int J Cancer; 2019 May; 144(9):2074-2081. PubMed ID: 30125343
[TBL] [Abstract][Full Text] [Related]
13. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation.
Capello M; Caorsi C; Bogantes Hernandez PJ; Dametto E; Bertinetto FE; Magistroni P; Rendine S; Amoroso A; Novelli F
Immunol Lett; 2015 Sep; 167(1):11-6. PubMed ID: 26096821
[TBL] [Abstract][Full Text] [Related]
15. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
[TBL] [Abstract][Full Text] [Related]
16. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines.
Pontecorvi P; Banki MA; Zampieri C; Zalfa C; Azmoon P; Kounnas MZ; Marchese C; Gonias SL; Mantuano E
J Neuroinflammation; 2019 Dec; 16(1):257. PubMed ID: 31810478
[TBL] [Abstract][Full Text] [Related]
18. Urokinase plasminogen activator receptor (CD87): something old, something new.
Ge Y; Elghetany MT
Lab Hematol; 2003; 9(2):67-71. PubMed ID: 12828301
[TBL] [Abstract][Full Text] [Related]
19. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.
Díaz VM; Hurtado M; Thomson TM; Reventós J; Paciucci R
Gut; 2004 Jul; 53(7):993-1000. PubMed ID: 15194650
[TBL] [Abstract][Full Text] [Related]
20. The role of plasminogen-plasmin system in cancer.
Kwaan HC; McMahon B
Cancer Treat Res; 2009; 148():43-66. PubMed ID: 19377918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
